Fundraising FoxVivo Panda
Venture capitalPalo Alto · 2 people tracked
Find your way into Vivo Panda
Each arrow is one introduction. Sign up to fill in the first one.
Ask Peary Spaght to introduce you to Michael Chang
You →Peary · together at Fletcher Spaght, Inc. →Michael
Ask Jamie Chen to introduce you to Mahendra G. Shah
You →Jamie · together at Crinetics Pharmaceuticals →Mahendra
Sign up to find every way you can get introduced to Vivo Panda
- Your email: who you already know at Vivo Panda, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vivo Panda team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Fund manager profile
Vivo Panda is a venture fund manager based in Palo Alto. SEC filings show 1 venture fund on record, most recently Vivo Panda Fund, L.P. ($100.3M offering) filed June 2016.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 2 people
from public directoriesWhat they invest in
from 2 of 2 portfolio companiesBiotech ×2Healthtech ×2
Investments · 2 tracked
founders shown can be your intro path
Q32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis.
BiotechHealthtech
Shelia Violette(Founder & Chief Scientific Officer)inMichael Holers(Co-founder)Jodie Morrison(Chief Executive Officer)inLee Kalowski(President & Chief Financial Officer)Maria Marzilli(Chief Business Officer)inDavid Appugliese(Senior Vice President, Head of People)in
Co-investorsAtlas VentureOrbiMedAgent CapitalCU Healthcare Innovation FundOUP (Osage University Partners)Sanofi Ventures+2 more
Verona Pharma develops treatments for chronic lung conditions.
BiotechHealthtechLondon
Jan-Anders Karlsson(Executive Officer, Director)inPeter Spargo(Executive Officer)inPatrick Humphrey(Director)Ken Cunningham(Director)Kenneth Newman(Executive Officer)Anders Ullman(Director)
Board seatMahendra Shah· per SEC Form D · $200.2M raise · filed Jul 2020
Co-investorsAccess BiotechnologyAisling CapitalAndera PartnersForesite CapitalFrazier Life SciencesNew Enterprise Associates (NEA)+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 IPOsQ32 BioNASDAQ: QTTB
Portfolio news
latest coverage across their companiesQ32 Bio · stocktitan.net · Jul 15, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Q32 Bio | 1.8% | $16.00 | Mar 2018 | $10.6M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- Where is Vivo Panda located?
- Vivo Panda is headquartered in Palo Alto, US.